Cargando…
Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009
In 2004, identification of patients infected with the same Mycobacterium tuberculosis strain in New York, New York, USA, resulted in an outbreak investigation. The investigation involved data collection and analysis, establishing links between patients, and forming transmission hypotheses. Fifty-fou...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166009/ https://www.ncbi.nlm.nih.gov/pubmed/21392426 http://dx.doi.org/10.3201/eid1703.101002 |
_version_ | 1782211104145932288 |
---|---|
author | Perri, Bianca R. Proops, Douglas Moonan, Patrick K. Munsiff, Sonal S. Kreiswirth, Barry N. Kurepina, Natalia Goranson, Christopher Ahuja, Shama D. |
author_facet | Perri, Bianca R. Proops, Douglas Moonan, Patrick K. Munsiff, Sonal S. Kreiswirth, Barry N. Kurepina, Natalia Goranson, Christopher Ahuja, Shama D. |
author_sort | Perri, Bianca R. |
collection | PubMed |
description | In 2004, identification of patients infected with the same Mycobacterium tuberculosis strain in New York, New York, USA, resulted in an outbreak investigation. The investigation involved data collection and analysis, establishing links between patients, and forming transmission hypotheses. Fifty-four geographically clustered cases were identified during 2003–2009. Initially, the M. tuberculosis strain was drug susceptible. However, in 2006, isoniazid resistance emerged, resulting in isoniazid-resistant M. tuberculosis among 17 (31%) patients. Compared with patients with drug-susceptible M. tuberculosis, a greater proportion of patients with isoniazid-resistant M. tuberculosis were US born and had a history of illegal drug use. No patients named one another as contacts. We used patient photographs to identify links between patients. Three links were associated with drug use among patients infected with isoniazid-resistant M. tuberculosis. The photographic method would have been more successful if used earlier in the investigation. Name-based contact investigation might not identify all contacts, particularly when illegal drug use is involved. |
format | Online Article Text |
id | pubmed-3166009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-31660092011-11-15 Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009 Perri, Bianca R. Proops, Douglas Moonan, Patrick K. Munsiff, Sonal S. Kreiswirth, Barry N. Kurepina, Natalia Goranson, Christopher Ahuja, Shama D. Emerg Infect Dis Research In 2004, identification of patients infected with the same Mycobacterium tuberculosis strain in New York, New York, USA, resulted in an outbreak investigation. The investigation involved data collection and analysis, establishing links between patients, and forming transmission hypotheses. Fifty-four geographically clustered cases were identified during 2003–2009. Initially, the M. tuberculosis strain was drug susceptible. However, in 2006, isoniazid resistance emerged, resulting in isoniazid-resistant M. tuberculosis among 17 (31%) patients. Compared with patients with drug-susceptible M. tuberculosis, a greater proportion of patients with isoniazid-resistant M. tuberculosis were US born and had a history of illegal drug use. No patients named one another as contacts. We used patient photographs to identify links between patients. Three links were associated with drug use among patients infected with isoniazid-resistant M. tuberculosis. The photographic method would have been more successful if used earlier in the investigation. Name-based contact investigation might not identify all contacts, particularly when illegal drug use is involved. Centers for Disease Control and Prevention 2011-03 /pmc/articles/PMC3166009/ /pubmed/21392426 http://dx.doi.org/10.3201/eid1703.101002 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Perri, Bianca R. Proops, Douglas Moonan, Patrick K. Munsiff, Sonal S. Kreiswirth, Barry N. Kurepina, Natalia Goranson, Christopher Ahuja, Shama D. Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009 |
title | Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009 |
title_full | Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009 |
title_fullStr | Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009 |
title_full_unstemmed | Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009 |
title_short | Mycobacterium tuberculosis Cluster with Developing Drug Resistance, New York, New York, USA, 2003–2009 |
title_sort | mycobacterium tuberculosis cluster with developing drug resistance, new york, new york, usa, 2003–2009 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166009/ https://www.ncbi.nlm.nih.gov/pubmed/21392426 http://dx.doi.org/10.3201/eid1703.101002 |
work_keys_str_mv | AT perribiancar mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009 AT proopsdouglas mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009 AT moonanpatrickk mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009 AT munsiffsonals mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009 AT kreiswirthbarryn mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009 AT kurepinanatalia mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009 AT goransonchristopher mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009 AT ahujashamad mycobacteriumtuberculosisclusterwithdevelopingdrugresistancenewyorknewyorkusa20032009 |